PDT Partners’s Aratana Therapeutics, Inc. PETX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-26,800
| Closed | -$138K | – | 513 |
|
|
2019
Q2 | $138K | Hold |
26,800
| – | – | 0.01% | 392 |
|
|
2019
Q1 | $96K | Sell |
26,800
-14,200
| -35% | -$50.9K | 0.01% | 415 |
|
|
2018
Q4 | $251K | Sell |
41,000
-25,218
| -38% | -$154K | 0.01% | 383 |
|
|
2018
Q3 | $387K | Buy |
66,218
+3,489
| +6% | +$20.4K | 0.02% | 384 |
|
|
2018
Q2 | $267K | Sell |
62,729
-56,371
| -47% | -$240K | 0.01% | 453 |
|
|
2018
Q1 | $525K | Hold |
119,100
| – | – | 0.02% | 430 |
|
|
2017
Q4 | $626K | Sell |
119,100
-8,700
| -7% | -$45.7K | 0.02% | 406 |
|
|
2017
Q3 | $783K | Sell |
127,800
-833
| -0.6% | -$5.1K | 0.03% | 384 |
|
|
2017
Q2 | $930K | Buy |
+128,633
| New | +$930K | 0.04% | 347 |
|
|
2017
Q1 | – | Sell |
-41,563
| Closed | -$298K | – | 561 |
|
|
2016
Q4 | $298K | Sell |
41,563
-44,775
| -52% | -$321K | 0.02% | 438 |
|
|
2016
Q3 | $808K | Hold |
86,338
| – | – | 0.05% | 325 |
|
|
2016
Q2 | $546K | Buy |
86,338
+39,800
| +86% | +$252K | 0.04% | 321 |
|
|
2016
Q1 | $257K | Buy |
46,538
+1,200
| +3% | +$6.63K | 0.02% | 485 |
|
|
2015
Q4 | $253K | Buy |
+45,338
| New | +$253K | 0.03% | 330 |
|
|
2014
Q4 | – | Sell |
-40,867
| Closed | -$410K | – | 1240 |
|
|
2014
Q3 | $410K | Buy |
+40,867
| New | +$410K | 0.01% | 1000 |
|